APA (7th ed.) Citation

Timar, B., Serafinceanu, C., Vlad, A., & Timar, R. (2016). The Emerging Role of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes. Focus on Dapagliflozin. Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 23(1), 113. https://doi.org/10.1515/rjdnmd-2016-0014

Chicago Style (17th ed.) Citation

Timar, Bogdan, Cristian Serafinceanu, Adrian Vlad, and Romulus Timar. "The Emerging Role of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes. Focus on Dapagliflozin." Romanian Journal of Diabetes Nutrition & Metabolic Diseases 23, no. 1 (2016): 113. https://doi.org/10.1515/rjdnmd-2016-0014.

MLA (9th ed.) Citation

Timar, Bogdan, et al. "The Emerging Role of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes. Focus on Dapagliflozin." Romanian Journal of Diabetes Nutrition & Metabolic Diseases, vol. 23, no. 1, 2016, p. 113, https://doi.org/10.1515/rjdnmd-2016-0014.